Back to Journals » Therapeutics and Clinical Risk Management » Volume 9

Developments in the treatment of moderate to severe ulcerative colitis: focus on adalimumab

Total article views   Abstract views HTML views PDF downloads Totals
7,904 Dovepress* 5,946 497+ 1,463 6,443
PubMed Central* 5 1,456 495 1,461
Totals 5,951 1,953 1,958 7,904
*Since 7 November 2013
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
6 0 0 0 3 3

View citations on PubMed Central and Google Scholar